Find stats on top websites
Industry Landscape
The life sciences CRDMO industry is currently experiencing robust growth, driven by increasing R&D outsourcing, technological advancements, and a growing pipeline of complex therapies. Companies are focusing on integrated end-to-end solutions, quality, and regulatory compliance. The demand for specialized services, especially in biologics and advanced therapies, continues to shape the market, emphasizing efficiency and cost-effectiveness.
Total Assets Under Management (AUM)
Contract Research Organization (CRO) Market Size in United States
~$43.6 Billion (2023)
(8.5% CAGR)
- Increasing R&D expenditure by pharmaceutical companies.
- Growing demand for outsourcing clinical trials.
- Advancements in drug discovery and development.
Total Addressable Market
57.5 billion USD